[11C]PF-06809247

N/A

Report date: 2026/03/10 17:27:59

Base Information

Drug Name[11C]PF-06809247

Drug Alias NameCarbon-11-PF 06809247[11C]PF-06809247

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Carbon > 11CDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5]

Mechanisms of ActionMonoglyceride lipase inhibitors

TargetsMonoglyceride lipase

Therapy Area/IndicationsNeuroinflammatory Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsNeuroinflammatory Diseases

Other Information

ATC CodeN/A